Le Lézard
Classified in: Health
Subject: PDT

Cymbiotika Relaunches Plant-Based Supplement, Elderberry, to Help Boost Immune Function

The all-natural formula helps protect against flus and viruses and shields the body from free radicals

SAN DIEGO, Aug. 16, 2022 /PRNewswire/ -- Cymbiotika, a leading nutritional supplement brand known for creating pure, clinically backed supplements, today announced the relaunch of its Elderberry. Elderberry is a powerful natural antiviral, packed with antioxidants and nutrients known for supporting the immune system and protecting the body through sickness. When combined with phosphatidylcholine and echinacea, this liposomal hypertonic enhances overall wellness year-round.

"Our team recognizes the power in the natural Vitamin C, quercetin, and phenolic acids that elderberry extract contains and its capabilities to enhance the immune system, which is why we reformulated this product to optimize these natural qualities even further," said Cymbiotika's CEO and Co-Founder, Shahab Elmi. "As we constantly work towards empowering consumers to reclaim their health with our offerings, we want to provide the best possible formulations, since these supplements can reduce the duration of sickness and help people quickly get back to a healthy life."

Cymbiotika's Elderberry Defense contains immune-boosting antioxidants that help the body produce white blood cells to effectively fight cold and flu viruses. 

Cymbiotika's Elderberry Defense retails for $48 and is available for purchase through the Cymbiotika website. Customers should take the product directly from the packet or mix it into water, juice, yogurt, or a smoothie. It May be taken at the onset of any cold, flu, or sinus inflammation to help ease symptoms. For enhanced immunity year-round, take alongside Cymbiotika's Liposomal Vitamin C. For more information, visit www.cymbiotika.com.

About Cymbiotika

Cymbiotika is an innovative wellness brand based in San Diego. With the motto, "Your mind and body deserve the best," Cymbiotika is driven by the higher purpose of inspiring everyday people to achieve their optimal health. Founded in 2017, Cymbiotika uses the most advanced bioavailable absorption technology and sources only the highest quality plant-based nutrients to resolve specific nutritional deficiencies and support healthy aging, detoxification and longevity. Cymbiotika never uses synthetics, GMOs, fillers, chemicals, preservatives, or additives in its products. For more information, visit www.cymbiotika.com.

SOURCE Cymbiotika

These press releases may also interest you

at 21:10
The FDA approves AMX0035, the first new treatment for ALS in years. The new treatment was funded by donations from the Ice Bucket Challenge, the 2014 social media phenomenon that swept the globe, with 17 million participants raising $115 million for...

at 20:36
Coco Life Foundation (Cocolife.black), launched in 2019, is a 501(c)(3) organization based in Philadelphia, PA. Its goal is to eliminate racial disparities in care and improve maternal health outcomes for Black mothers nationwide. Essential services...

at 19:31
The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of sodium phenylbutyrate/taurursodiol (Relyvrio) for the treatment of amyotrophic lateral sclerosis (ALS), on September 29. Relyvrio will be made...

at 19:30
Vitality Products Inc. (the "Company" or "Vitality") is pleased to report its financial results for the second quarter ended July 31, 2022....

at 19:30
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the European Medicines Agency (EMA) has accepted for regulatory review the company's marketing authorization application (MAA) for fezolinetant, an...

at 19:15
The report "Diuretic Drugs Market by Product Type and Geography - Forecast and Analysis 2022-2026" has been added to Technavio's offerings. The market size is anticipated to grow by USD 95.64 million from 2021 to 2026. In addition, the growth...

News published on 16 august 2022 at 11:00 and distributed by: